Northern Trust Corp Sc Pharmaceuticals Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 255,134 shares of SCPH stock, worth $870,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares

255,134

Previous 247,922 2.91%

Holding current value

$870,006

Previous $1.08 Million 7.88%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.12 - $5.51 $29,713 - $39,738	7,212 Added 2.91%	255,134 $1.16 Million
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $59,273 - $87,981	-16,887 Reduced 6.38%	247,922 $1.08 Million
Q1 2024 May 14, 2024	SELL	$4.86 - $6.39 $20,543 - $27,010	-4,227 Reduced 1.57%	264,809 $1.33 Million
Q4 2023 Feb 13, 2024	BUY	$4.7 - $6.63 $263 - $371	56 Added 0.02%	269,036 $1.69 Million
Q3 2023 Nov 13, 2023	BUY	$7.0 - $9.82 $68,621 - $96,265	9,803 Added 3.78%	268,980 $1.92 Million
Q2 2023 Aug 11, 2023	BUY	$8.94 - $11.74 $1.75 Million - $2.3 Million	195,525 Added 307.18%	259,177 $2.64 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $80,121 - $135,733	14,333 Added 29.06%	63,652 $577,000
Q4 2022 Feb 13, 2023	SELL	$4.02 - $7.53 $1,061 - $1,987	-264 Reduced 0.53%	49,319 $353,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.52 $6,616 - $9,630	1,477 Added 3.07%	49,583 $323,000
Q2 2022 Aug 12, 2022	SELL	$4.3 - $6.48 $3,448 - $5,196	-802 Reduced 1.64%	48,106 $232,000
Q1 2022 May 13, 2022	SELL	$3.9 - $6.11 $3,127 - $4,900	-802 Reduced 1.61%	48,908 $278,000
Q4 2021 Feb 08, 2022	SELL	$3.88 - $6.9 $1,552 - $2,760	-400 Reduced 0.8%	49,710 $249,000
Q3 2021 Nov 15, 2021	BUY	$4.93 - $7.15 $1,109 - $1,608	225 Added 0.45%	50,110 $333,000
Q2 2021 Aug 13, 2021	SELL	$5.19 - $7.38 $337,287 - $479,611	-64,988 Reduced 56.57%	49,885 $305,000
Q1 2021 May 12, 2021	SELL	$5.65 - $7.66 $138,334 - $187,547	-24,484 Reduced 17.57%	114,873 $764,000
Q4 2020 Feb 11, 2021	SELL	$5.17 - $9.41 $33,594 - $61,146	-6,498 Reduced 4.46%	139,357 $737,000
Q3 2020 Nov 16, 2020	BUY	$7.12 - $8.86 $264,700 - $329,388	37,177 Added 34.21%	145,855 $1.09 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $761,832 - $1.19 Million	108,678 New	108,678 $799,000
Q4 2019 Feb 14, 2020	SELL	$4.1 - $6.21 $42,746 - $64,745	-10,426 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$3.24 - $7.35 $181,906 - $412,658	-56,144 Reduced 84.34%	10,426 $62,000
Q2 2019 Aug 13, 2019	SELL	$2.48 - $3.76 $5,190 - $7,869	-2,093 Reduced 3.05%	66,570 $213,000
Q1 2019 May 13, 2019	SELL	$2.84 - $4.18 $712 - $1,049	-251 Reduced 0.36%	68,663 $206,000
Q4 2018 Feb 12, 2019	BUY	$3.76 - $5.61 $308 - $460	82 Added 0.12%	68,914 $259,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $6.03 $3,798 - $5,427	900 Added 1.32%	68,832 $404,000
Q2 2018 Aug 14, 2018	BUY	$5.53 - $15.4 $110,306 - $307,183	19,947 Added 41.57%	67,932 $384,000
Q1 2018 May 09, 2018	BUY	$11.62 - $17.32 $557,585 - $831,100	47,985 New	47,985 $595,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $93.4M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Sc Pharmaceuticals Inc. Transaction History